Vanguard Group’s BIO-key International BKYI Stock Holding History
Bought
Maintained
Sold
Other funds holding BKYI
FTUS
TRCT
SRCM
SS
Vanguard Group's BKYI Position: Q4 2025 in Review
Vanguard Group reduced its BIO-key International (BKYI) stake by 5.6% in Q4 2025, selling an estimated $1.59K and leaving 3,485 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4309.
Vanguard Group first reported a position in BKYI in Q3 2018 and has held it in 23 quarters since. The position peaked at $977K in Q2 2021. 14 funds tracked by Wall St. Rank hold BKYI as of Q4 2025.
- Vanguard Group held 3,485 shares of BIO-key International worth $18.8K as of Q4 2025.
- Vanguard Group sold 208 BIO-key International shares in Q4 2025, an estimated $1.59K.
- BIO-key International made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4309 holding.
- Vanguard Group first reported a position in BIO-key International in Q3 2018 and has held it in 23 quarters since.
- Vanguard Group's BIO-key International position peaked at $977K in Q2 2021.
- 14 funds tracked by Wall St. Rank held BIO-key International as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.